What is DocGo's cash & equivalents?

DocGo (DCGO) reported cash & equivalents of $46.82M in Q1 2026.

How has DocGo's cash & equivalents changed year-over-year?

DocGo's cash & equivalents decreased by 54.6% year-over-year, from $103.06M to $46.82M.

What is the long-term trend for DocGo's cash & equivalents?

Over 5 years (2020 to 2025), DocGo's cash & equivalents has grown at a 157.3% compound annual growth rate (CAGR), from $465K to $52.48M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

DocGo DCGO Cash & Equivalents

Cash & Equivalents at other companies

CVS HealthCVS

$9.77B-5.6%

Option Care Health, Inc.OPCH

$177.32M+3.5%

AmazonAMZN

$101.82B+53.8%

Teladoc HealthTDOC

$750.74M-37.1%

BrightSpring Health Services, Inc.BTSG

$888.8M+1,598%

Viemed Healthcare, Inc.VMD

$9.76M-3.9%

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-69.6%

Enterprise value$32.67M-63.4%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's cash & equivalents?: DocGo (DCGO) reported cash & equivalents of $46.82M in Q1 2026.
How has DocGo's cash & equivalents changed year-over-year?: DocGo's cash & equivalents decreased by 54.6% year-over-year, from $103.06M to $46.82M.
What is the long-term trend for DocGo's cash & equivalents?: Over 5 years (2020 to 2025), DocGo's cash & equivalents has grown at a 157.3% compound annual growth rate (CAGR), from $465K to $52.48M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.